COVID-19大流行期间的流感疫苗接种——美国11个司法管辖区,2020年9月至12月
为评估COVID-19大流行对流感疫苗接种覆盖率的影响,比较了美国11个高性能州免疫信息系统的司法管辖区2020年9月至12月至少接种1剂流感疫苗的百分比变化与2018年和2019年同期的平均接种量。总体而言,2020年流感疫苗接种量较2018年和2019年合并平均高9.0%,但6-23月龄和2-4岁儿童接种量分别低13.9%和11.9%。
要点
- 2020年9-12月总体流感疫苗接种量较2018-2019年同期平均高9.0%。
- 6-23月龄儿童接种量较2018-2019年平均低13.9%。
- 2-4岁儿童接种量较2018-2019年平均低11.9%。
核心结论
- 2020年总体流感疫苗接种量较2018年和2019年合并平均高9.0%,但6-23月龄和2-4岁儿童接种量分别低13.9%和11.9%。
- 需要战略性努力确保所有年龄组的高流感疫苗接种覆盖率,尤其是尚未有资格接种COVID-19疫苗的6月龄至4岁儿童。
- 在符合条件的人群中同时接种流感疫苗和COVID-19疫苗尤为重要,以减少流感与COVID-19病例可能给本已因COVID-19而不堪重负的卫生保健系统带来的潜在压力。
研究设计与样本
- 分析美国11个具有高性能州免疫信息系统的司法管辖区报告的流感疫苗接种数据。
- 比较2020年9月至12月至少接种1剂流感疫苗的百分比变化与2018年和2019年同期的平均接种量。
主要发现
- 2020年流感疫苗接种量较2018年和2019年合并平均高9.0%。
- 2020年6-23月龄儿童流感疫苗接种量较2018年和2019年该年龄组平均低13.9%。
- 2020年2-4岁儿童流感疫苗接种量较2018年和2019年该年龄组平均低11.9%。
关键数值与推荐
- 免疫实践咨询委员会(ACIP)推荐所有≥6月龄且无禁忌证的人群在2021-22流感季节常规每年接种流感疫苗。
临床怎么用
- 需要战略性努力确保所有年龄组的高流感疫苗接种覆盖率,尤其是6月龄至4岁儿童。
- 在符合条件的人群中同时接种流感疫苗和COVID-19疫苗尤为重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza causes considerable morbidity and mortality in the United States. Between 2010 and 2020, an estimated 9-41 million cases resulted in 140,000-710,000 hospitalizations and 12,000-52,000 deaths annually (1). As the United States enters the 2021-22 influenza season, the potential impact of influenza illnesses is of concern given that influenza season will again coincide with the ongoing COVID-19 pandemic, which could further strain overburdened health care systems. The Advisory Committee on Immunization Practices (ACIP) recommends routine annual influenza vaccination for the 2021-22 influenza season for all persons aged ≥6 months who have no contraindications (2). To assess the potential impact of the COVID-19 pandemic on influenza vaccination coverage, the percentage change between administration of at least 1 dose of influenza vaccine during September-December 2020 was compared with the average administered in the corresponding periods in 2018 and 2019. The data analyzed were reported from 11 U.S. jurisdictions with high-performing state immunization information systems.* Overall, influenza vaccine administration was 9.0% higher in 2020 compared with the average in 2018 and 2019, combined. However, in 2020, the number of influenza vaccine doses administered to children aged 6-23 months and children aged 2-4 years, was 13.9% and 11.9% lower, respectively than the average for each age group in 2018 and 2019. Strategic efforts are needed to ensure high influenza vaccination coverage among all age groups, especially children aged 6 months-4 years who are not yet eligible to receive a COVID-19 vaccine. Administration of influenza vaccine and a COVID-19 vaccine among eligible populations is especially important to reduce the potential strain that influenza and COVID-19 cases could place on health care systems already overburdened by COVID-19.
引用
- Roman PC, Kirtland K, Zell ER, et al. Influenza Vaccinations During the COVID-19 Pandemic - 11 U.S. Jurisdictions, September-December 2020. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34758010. doi:10.15585/mmwr.mm7045a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。